Buy Depakote 125 mg/1 Divalproex Sodium

Depakote 125 mg is a delayed-release tablet containing divalproex sodium, used for managing certain types of seizures and mood disorders. This medication is designed to provide controlled release of the active ingredient for consistent effects.

Strength

125 mg/1

Pack Size

100 TABLET, DELAYED RELEASE in 1 BOTTLE (0074-7325-13)

Manufacturer / TM Owner

AbbVie Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Depakote 125 mg is commonly prescribed for the treatment of epilepsy, helping to control seizures by stabilizing electrical activity in the brain. It is also used in the management of bipolar disorder, particularly for preventing manic episodes. The medication works by increasing the levels of a natural substance in the brain called GABA, which helps to calm overactive nerve cells.

Side Effects

Common effects of Depakote 125 mg may include drowsiness, dizziness, and nausea. Some users might experience weight changes or tremors. These effects can vary from person to person and may diminish as the body adjusts to the medication.

Precautions & Warnings

Depakote 125 mg should be handled with care, especially by individuals with liver or pancreatic conditions. Regular monitoring of liver function may be recommended. It is important to follow the advice of a healthcare provider regarding the use of this medication, particularly if you have a history of metabolic disorders or are pregnant.

Avoid Interactions

Depakote 125 mg may interact with other medications, including those that affect the liver or central nervous system. Alcohol and certain over-the-counter drugs can also influence its effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

References

Frequently Asked Questions

Depakote 125 mg is used to manage certain types of seizures and to prevent manic episodes in bipolar disorder.

Depakote 125 mg is taken orally, typically with food to minimize stomach upset.

Common side effects include drowsiness, dizziness, nausea, weight changes, and tremors.

Depakote 125 mg may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

The safety of Depakote 125 mg during pregnancy should be discussed with a healthcare provider, as it may have potential risks.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.